Join us for an exciting on-demand video masterclass designed to revolutionize your approach to ovarian cancer care! Dive into the critical distinctions between low-grade serous ovarian carcinoma (LGSOC) and high-grade serous ovarian carcinoma (HGSOC), and uncover the unique epidemiology, pathophysiology, and disease biology that set them apart. Equip yourself with cutting-edge, evidence-based strategies from leading experts to ensure prompt and accurate diagnosis of LGSOC. Plus, stay ahead of the curve by exploring the latest clinical breakthroughs in emerging therapies that could transform the treatment landscape for LGSOC. Don’t miss this opportunity to elevate your clinical expertise and make a real difference in the lives of patients with rare ovarian cancers.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/equipping-oncology-teams-latest-evidence-emerging-therapies-low-grade-serous
- Start Date: 2024-10-18 05:00:00
- End Date: 2024-10-18 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Verastem Oncology - Amount: 48333.33 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology